[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ceapro Inc (CRPOF)

Ceapro Inc (CRPOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 13,310
  • Shares Outstanding, K 78,293
  • Annual Sales, $ 7,140 K
  • Annual Income, $ -3,490 K
  • EBIT $ -3 M
  • EBITDA $ 6 M
  • 60-Month Beta 1.47
  • Price/Sales 2.14
  • Price/Cash Flow 2.74
  • Price/Book 0.60
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.02 on 05/29/24
  • Next Earnings Date 09/03/24
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1700 unch
on 05/31/24
0.2200 -22.73%
on 05/15/24
-0.0145 (-7.86%)
since 04/22/24
3-Month
0.1618 +5.07%
on 03/08/24
0.2200 -22.73%
on 05/15/24
+0.0100 (+6.25%)
since 02/28/24
52-Week
0.1146 +48.34%
on 01/29/24
0.3994 -57.44%
on 06/09/23
-0.1600 (-48.48%)
since 05/26/23

Most Recent Stories

More News
Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop an Inhalable Immuno-Therapeutic/-Prophylactic for COVID-19-Induced Lung Fibrosis

– Continuation of research with McMaster University to validate the anti-fibrotic properties of the Company’s PGX-Processed yeast beta glucan in...

CZO.VN : 0.225 (-11.76%)
CRPOF : 0.1700 (-13.04%)
Ceapro Inc. Announces Publication of Positive Results for PGX-Processed Alginates Impregnated with CoQ10 in The Journal of Supercritical Fluids

– PGX Technology continues to demonstrate the ability to generate superior novel bioactive delivery systems – Findings from the collaborative project with...

CZO.VN : 0.225 (-11.76%)
CRPOF : 0.1700 (-13.04%)
Ceapro Bolsters Executive Management Team with Appointment of Sigrun Watson as Chief Revenue Officer

Recognized commercial leader with over 20 years of experience across diverse healthcare industries Appointment marks strategic step in driving Company...

CZO.VN : 0.225 (-11.76%)
CRPOF : 0.1700 (-13.04%)
Ceapro Announces Results of 2022 Shareholders’ Meeting

EDMONTON, Alberta, June 07, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology...

CZO.VN : 0.225 (-11.76%)
CRPOF : 0.1700 (-13.04%)
Ceapro Inc. to Present at the H.C. Wainwright Global Investment Conference

EDMONTON, Alberta, May 23, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc.  (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology...

CZO.VN : 0.225 (-11.76%)
CRPOF : 0.1700 (-13.04%)
Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update

– Best quarterly financial results in history of the Company – Q1 2022 sales of $6,172,000 vs $4,702,000 in Q1 2021, a 31% increase – Operating profit...

CZO.VN : 0.225 (-11.76%)
CRPOF : 0.1700 (-13.04%)
Ceapro Inc. Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids

PGX Technology continues to demonstrate ability to generate novel bioactive delivery systems for nutraceuticals, drug delivery and wound healing...

CZO.VN : 0.225 (-11.76%)
CRPOF : 0.1700 (-13.04%)
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th

- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ / ACCESSWIRE...

OTLK : 0.2526 (+1.04%)
CRBP : 9.90 (+0.20%)
AEZS.TO : 8.29 (+8.08%)
CZO.VN : 0.225 (-11.76%)
AEZS : 5.72 (+5.93%)
AIM : 0.5207 (+0.40%)
SING : 0.0001 (unch)
NVNO : 10.04 (-3.83%)
CRPOF : 0.1700 (-13.04%)
AREC : 2.31 (-0.43%)
CYTH : 0.7206 (+1.39%)
CNSP : 2.33 (+2.63%)
JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th

- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating companies...

OTLK : 0.2526 (+1.04%)
AREC : 2.31 (-0.43%)
CZO.VN : 0.225 (-11.76%)
CYTH : 0.7206 (+1.39%)
CNSP : 2.33 (+2.63%)
SING : 0.0001 (unch)
NVNO : 10.04 (-3.83%)
NOVN : 0.0941 (-24.84%)
VLON : 0.4000 (-13.04%)
CRPOF : 0.1700 (-13.04%)
MBRX : 2.52 (-1.56%)

Business Summary

Ceapro Inc. is a biotechnology company. The company develop and commercialize ingredients for human and animal health markets. Its product pipeline includes botanical product & oat product. The company's technology consists of PGX Technology. Ceapro Inc. is headquartered in Edmonton, Canada.

See More

Key Turning Points

3rd Resistance Point 0.1700
2nd Resistance Point 0.1700
1st Resistance Point 0.1700
Last Price 0.1700
1st Support Level 0.1700
2nd Support Level 0.1700
3rd Support Level 0.1700

See More

52-Week High 0.3994
Fibonacci 61.8% 0.2906
Fibonacci 50% 0.2570
Fibonacci 38.2% 0.2234
Last Price 0.1700
52-Week Low 0.1146

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.